LabAssay (TM) NEFA
- Manufacturer :
- FUJIFILM Wako Shibayagi Corporation
- Storage Condition :
- Keep at 2-10 degrees C.
- GHS :
-
- Structural Formula
- Label
- Packing
Comparison
|
Product Number
|
Package Size
|
Price
|
Inventory
|
||
---|---|---|---|---|---|---|
|
|
500Tests
|
|
In stock in Japan |
|
|
Document
Kit component
Kit component
Chromogen Reagent A | for 10 mL x 4 vials |
---|---|
Solvent A | 45 mL x 1 vial |
Chromogen Reagent B | for 20 mL x 4 vials |
Solvent B | 90 mL x 1 vial |
Standard Solution (1mEq/L of Oleic acid) *amount of oleic acid; 1mEq=1mmol | 7 mL x 1 vial |
Overview
※For research purposes only with animal serum/plasma, Not for Diagnostic Use.
Introduction
NEFA (Non‐esterified fatty acid) in the blood is transported complexed with an albumin to peripheral tissues. They are important sources of fuel for the peripheral tissues. The concentration of NEFA in the blood is regulated by a release from the adipose tissues, a consumption in the periphral tissues or a take up from the liver.
Assay principle
NEFA (Non‐esterified fatty acid) forms Acyl-CoA in the presence of Acyl-CoA synthetase (ACS). Hydrogen peroxide, which is produced by a reaction between the Acyl-CoA and Acyl-CoA oxidase (ACOD), promotes oxidative condensation of 3-methyl-N-ethyl-N-(β-hydroxyethyl)-aniline (MEHA) with 4-aminoantipyrine. LabAssay™ NEFA can be used for the quantitative determination of NEFA in samples by measuring absorbance of a blue purple color which is generated by the oxidative condensation reaction.
-
Performance
Sample Serum, plasma(Mouse, Rat, dog, cat) Standard curve range 0.4~1.97 mEq/L Measurement time approx. 20 min. Amount of sample 4 μL Measurement wavelength 550 nm -
Standard Curve
Procedure
Assay in a microplate
Perform the assay in the wells according to the following table scheme.
No. | Standard Solution | Distilled or deionized water | Sample volume | Concentration |
---|---|---|---|---|
1 | 80 µL | 120 µL | 4 μL | 0.40 mEq/L |
2 | 120 µL | 80 µL | 4 μL | 0.60 mEq/L |
3 | 160 µL | 40 µL | 4 μL | 0.80 mEq/L |
4 | Undiluted | - | 4 μL | 1.00 mEq/L |
5 | Undiluted | - | 8 μL | 1.97 mEq/L*1 |
*1: The test sample volume is usually 4 μL, but 8 μL is taken in this case. The NEFA concentration must be corrected accordingly as indicated in the table above.
Data
Spike-and-Recovery Test
Spike and Recovery Test of NEFA, a known amount of standard is spiked into in mouse and rat sample n=2.
-
Rat Sample
Spike
(mEq/L)Mean
(mEq/L)Recovery
(mEq/L)Recovery
(%)Serum - 0.57 0.40 1.00 0.43 106.4% 0.61 1.21 0.65 106.2% 0.78 1.40 0.83 106.4% 1.01 1.57 1.01 99.7% Plasma
(EDTA)- 0.41 0.40 0.86 0.45 111.5% 0.61 1.07 0.66 108.5% 0.78 1.27 0.86 109.5% 1.01 1.44 1.02 101.4% -
Mouse Sample
Spike
(mEq/L)Mean
(mEq/L)Recovery
(mEq/L)Recovery
(%)Serum - 0.70 0.40 1.07 0.37 91.7% 0.61 1.31 0.61 100.1% 0.78 1.44 0.74 94.5% 1.01 1.62 0.92 91.3% Plasma
(EDTA)- 0.62 0.40 0.99 0.37 92.5% 0.61 1.29 0.68 111.5% 0.78 1.38 0.77 97.8% 1.01 1.62 1.00 99.1%
Linearity-of-Dilution Test
-
Rat sample
-
Mouse sample
-
D-MEM/10% FBS
Examples of measurement
-
20% Diluted Nomal Mouse serum, CD-1(ICR), male No. Mean (mEq/L) SD CV(%) 1 1.118 0.001 0.1 2 0.788 0.007 0.9 3 0.715 0.022 3.1 4 0.794 0.002 0.2 5 0.829 0.005 0.6 -
Nomal Mouse plasma K2EDTA, CD-1(ICR), male No. Mean SD CV(%) 1 *0.309 0.002 0.6 2 *0.320 0.002 0.6 3 *0.205 0.004 2.0 4 *0.179 0.008 4.6 5 *0.305 0.017 5.6
-
10% Diluted Nomal Rat serum, Sprague Dawley, male No. Mean SD CV(%) 1 *0.300 0 0.0 2 *0.371 0.004 1.1 3 *0.289 0.017 5.8 4 *0.365 0 0.1 5 *0.382 0.029 7.6 -
Nomal Rat plasma K2EDTA, Sprague Dawley, male No. Mean SD CV(%) 1 *0.333 0.004 1.2 2 *0.356 0.003 0.8 3 *0.325 0.020 6.0 4 *0.218 0.005 2.6 5 0.515 0.010 1.9
-
Nomal Canine serum, Beagle, male No. Mean (mEq/L) SD CV(%) Age(years) 1 0.656 0.0027 0.4 4 2 0.665 0.0320 4.8 6 3 0.425 0.0090 2.0 6 4 *0.38 0.0057 1.5 11 5 0.882 0.0070 0.8 12 6 0.599 0.0060 1.1 6 7 1.006 0.0267 2.7 10 8 0.506 0.0060 1.2 4 -
Nomal Canine plasma EDTA, Beagle, male No. Mean (mEq/L) SD CV(%) Age(years) 1 0.442 0.0033 0.7 4 2 0.427 0.0110 2.6 6 3 *0.308 0.0037 1.2 10 4 0.478 0.0123 2.6 12 5 0.473 0.0050 1.0 6 6 *0.367 0.0047 1.2 11 7 0.780 0.0133 1.7 10 8 0.411 0.0387 9.4 12
-
Nomal Feline serum, Short hair, male No. Mean (mEq/L) SD CV(%) Age(years) 1 0.717 0.0117 1.6 3 2 0.635 0.0100 1.6 3 3 1.004 0.0053 0.5 6 4 0.981 0.0093 0.9 4 5 0.636 0.0170 2.7 6 6 1.193 0.0267 2.3 6 7 1.022 0.0893 8.8 1 8 *0.382 0.0157 4.1 1 -
Nomal Feline plasma EDTA, Short hair, male No. Mean (mEq/L) SD CV(%) Age(years) 1 1.099 0.0103 0.9 0.5 2 *0.174 0.0033 2.0 1 3 *0.241 0.0043 1.7 3 4 *0.320 0.0067 2.2 0.5 5 *0.359 0.0060 1.7 3 6 *0.197 0.0120 6.2 3 7 *0.215 0.0240 11.1 0.5 8 *0.131 0.0160 12.3 1
References
Kobayashi, Y. et al. : J. Pharmacogn. Nat. Prod., online (2015). Effects of Morus alba L. (Mulberry) Leaf Extract in Hypercholesterolemic Mice on Suppression of Cholesterol Synthesis *Extraction liquid of mouse liver
Gao, F. et al. : Evid. Based Complement. Alternat. Med., 2015, 801291 (2015). Effect of Keishibukuryogan on Genetic and Dietary Obesity Models *Extraction liquid of rat liver
Ogawa, K. et al. : Reprod. Med. Biol., online (2018). Non-esterified fatty acid-associated ability of follicular fluid to support porcine oocyte maturation and development *Pig cumulus-oocyte complexes
Wang, F. et al. : J. Mol. Endocrinol., 52, 133 (2014). LGR4 acts as a link between the peripheral circadian clock and lipid metabolism in liver *Mouse plasma
Uchida, K. et al. : Exp. Anim., 58, 181 (2009). Hyperlipidemia and hyperinsulinemia in the spontaneous osteoarthritis mouse model, STR/Ort *Mouse serum
Overview / Applications
Property
Manufacturer Information
Alias
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.